Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron A Diaz

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Neuro-Oncology|April 17, 2020
Exosomal PD-L1 induces immunosuppressive nonclassical monocytesAaron A Diaz
Neuro-Oncology|March 2, 2022
Loss of ATRX suppresses anti-tumor immunityAaron A Diaz
Nucleic Acids Research|November 28, 2014
HiTSelect: a comprehensive tool for high-complexity-pooled screen analysisAaron A Diaz, Han Qin, Miguel Ramalho-Santos, et al.
Genome Biology|January 27, 2021
The evolution of alternative splicing in glioblastoma under therapyLin Wang, Karin Shamardani, Husam Babikir, et al.
Genome Biology|November 12, 2021
ATRX regulates glial identity and the tumor microenvironment in IDH-mutant gliomaHusam Babikir, Lin Wang, Karin Shamardani, et al.
Nature Cancer|December 20, 2022
A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targetsLin Wang, Jangham Jung, Husam Babikir, et al.
Genome Biology|April 16, 2016
Single-cell analysis of long non-coding RNAs in the developing human neocortexSiyuan John Liu, Tomasz J Nowakowski, Alex A Pollen, et al.
Cancer Discovery|September 27, 2019
The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of VariationLin Wang, Husam Babikir, Sören Müller, et al.
Molecular Therapy. Oncology|April 20, 2026
AAV immuno-gene therapy platform delivering vectorized cytokines defines a new modality for high-grade glioma treatmentAkela Kuwahara, Ethan M Fenton, Chris Lovejoy, et al.
Cancer Research|February 12, 2020
Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy ResistanceAnkush Chandra, Arman Jahangiri, William Chen, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Neuro-Oncology|April 17, 2020
Exosomal PD-L1 induces immunosuppressive nonclassical monocytesAaron A Diaz
Neuro-Oncology|March 2, 2022
Loss of ATRX suppresses anti-tumor immunityAaron A Diaz
Nucleic Acids Research|November 28, 2014
HiTSelect: a comprehensive tool for high-complexity-pooled screen analysisAaron A Diaz, Han Qin, Miguel Ramalho-Santos, et al.
Genome Biology|January 27, 2021
The evolution of alternative splicing in glioblastoma under therapyLin Wang, Karin Shamardani, Husam Babikir, et al.
Genome Biology|November 12, 2021
ATRX regulates glial identity and the tumor microenvironment in IDH-mutant gliomaHusam Babikir, Lin Wang, Karin Shamardani, et al.
Nature Cancer|December 20, 2022
A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targetsLin Wang, Jangham Jung, Husam Babikir, et al.
Genome Biology|April 16, 2016
Single-cell analysis of long non-coding RNAs in the developing human neocortexSiyuan John Liu, Tomasz J Nowakowski, Alex A Pollen, et al.
Cancer Discovery|September 27, 2019
The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of VariationLin Wang, Husam Babikir, Sören Müller, et al.
Molecular Therapy. Oncology|April 20, 2026
AAV immuno-gene therapy platform delivering vectorized cytokines defines a new modality for high-grade glioma treatmentAkela Kuwahara, Ethan M Fenton, Chris Lovejoy, et al.
Cancer Research|February 12, 2020
Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy ResistanceAnkush Chandra, Arman Jahangiri, William Chen, et al.
Pageof 2